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Abstract Gastrointestinal symptoms accompanying
Lyme disease have not been considered in the treatment
of Lyme patients yet. Here we examine the eﬀect of
ranitidine bismuth citrate (RBC) on motile and cystic
forms of Borrelia burgdorferi in vitro, to determine
whether it could cure this bacterial infection in the gas-
trointestinal tract. When motile forms of B. burgdorferi
were exposed to RBC for 1 week at 37 C, the minimal
bactericidal concentration (MBC) was >64 mg/ml. At
30 C, the MBC was >256 mg/ml. When the incubation
lasted for 2 weeks at 37 C, the MBC dropped to
>2 mg/ml. Bismuth aggregates were present on the
surface of B. burgdorferi when RBC ‡ MBC, as shown
by transmission electron microscopy (TEM). Cystic
forms of B. burgdorferi, exposed to RBC for 2 weeks at
37 C, were examined by cultivation in BSK-H medium
(Sigma B3528). They were stained with acridine orange
(pH 6.4, pH 7.4) and studied by TEM. The MBC for
RBC for young cystic forms (1 day old) and old cysts
(8 months old) was estimated to be >0.125 mg/ml and
>2 mg/ml, respectively. Bismuth aggregates were
attached to the cysts and, in some, the pin-shaped ag-
gregates penetrated the cyst wall. The bismuth aggre-
gates also bound strongly to blebs and granules of
B. burgdorferi when RBC ‡ MBC. When B. burgdorferi
is responsible for gastrointestinal symptoms, bismuth
compounds may be candidates for eradication of the
bacterium from the gastrointestinal tract.
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Introduction
Lyme disease, caused by Borrelia burgdorferi and diﬃ-
cult to cure, may develop into a chronic infection if not
treated early. All antibiotics commonly used have
shortcomings. Eventual relapse may be highly depen-
dent on the choice of antibiotics and the stage of the
disease [22, 23, 32, 33, 34, 35, 37, 38]. One reason why
the infection can relapse may be that commonly used
antibiotics stimulate the conversion of B. burgdorferi
from mobile to cystic forms [17, 18, 27, 39, 40]. The cysts
convert back to motile spirochetes under favorable cir-
cumstances; and this may be one reason for reactivation
[1, 5, 6, 7]. The bacteria spread early in the progression
of infection [25], such that all organs and tissues may be
infected. Until recently, B. burgdorferi was thought to be
manifest in the skin, muscles, skeleton, cardiovascular
system, eyes, central and periphery nervous system,
genitourinary tract, lymphatic system, liver, kidneys,
bronchi and lungs [16, 41]. Recently, PCR was used on
biopsies from the gastrointestinal (GI) tract to detect
B. burgdorferi infection in the gut of patients with eryt-
hema migrans and gastrointestinal pain [15]. New in-
sights into the life history of the bacterium show that the
GI tract must be considered a sanctuary for this bacte-
rium, implying insuﬃcient treatment of Borrelia infec-
tions [15].
For the past 300 years, bismuth salts have been used
successfully in gastroenterology for the treatment of
stomatitis, ﬂatulence, diarrhoea, abdominal pain,
constipation, dyspepsia and peptic ulcer disease [19].
Certain enteropathogenic bacteria and viruses are
also susceptible to bismuth salts, including Clostridium
diﬃcile and Helicobacter pylori [12, 14, 28]. Bismuth
subsalicylate, which also has antisecretory properties,
prevents ﬂuid accumulation caused by enterotoxins and
is widely used for travellers’ diarrhoea [4, 13]. Before the
introduction of penicillin, bismuth was reported to cure
neurosyphilis [43]. The mechanism of action of bismuth
is not fully understood, but it has been proposed to
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inhibit the following functions: ATPase function, pro-
tein synthesis, membrane function and cell wall synthesis
[19]. In H. pylori, another bacterium that transforms to
coccoid (cystoid) forms and reverts to normal motile
forms [2], treatment with two or more antibiotics has
been established in combination with bismuth com-
pounds. Bismuth compounds act synergetically with
antibiotics. Infections with antibiotic-resistant strains of
H. pylori have been cured by a combination of bismuth
and antibiotics [20, 30].
High concentrations of bismuth are tolerated in the
GI tract [19, 20, 21] without severe adverse eﬀects [14].
Therefore, our hypothesis is that bismuth compounds
may inhibit motile and cystic forms of B. burgdorferi,
which portends well for the eradication of B. burgdorferi
from GI tract-infected patients.
Materials and methods
The bacterial strain used in our experiments was B. burgdorferi
ACA-1 (originally isolated in Sweden by Eva A˚sbrink, Department
of Dermatology, Karolinska Institute, So¨dersjukhuset, Stockholm,
Sweden) [3].
Production of spirochetes
A bacterial culture in exponential growth (0.1 ml) was transferred
to 4 ml BSK-H medium (Sigma B3528) [36]. The concentration of
inactivated (56 C, 30 min) rabbit serum (Sigma R7136) in the
BSK-H medium was 6%; and this serum was tested to be free of
antibodies against B. burgdorferi by the manufacturing company
(Sigma, St. Louis, Mo.). Passage of all culture media through a
sterile 0.2-lm ﬁlter ensued both sterility and the absence of mam-
malian cells from the serum. All cultures were incubated in sterile
5-ml closed tubes (Nalgene cryovial; Nalge, Rotherwick, UK) at
30 C.
Production of cystic forms
After 1 week of cultivation, the tube was centrifuged at 3,200 g for
30 min. The sediment and 0.5 ml of the supernatant were mixed
(108 motile spirochetes/ml, no cysts observed). This mixture of
sediment and supernatant was diluted 1:100 in distilled water at
4 C. The concentration of bacteria in the distilled water was
106 bacteria/ml. Samples of the culture were incubated for 24 h or
for 8 months, both at 30 C. The number of spirochetes and/or
cysts was in all cases determined by microscopy in 10 ll of medium
by dark ﬁeld microscopy (DFM), (200–800 · , Zeiss Axiophot;
Carl Zeiss, Oberkochen, Germany).
Susceptibility testing with ranitidine bismuth citrate
to cystic forms
Bismuth salts are sparingly soluble, so ranitidine bismuth citrate
(RBC) was chosen because it is completely soluble in water [19].
RBC (400 mg; Glaxo Welcome, Oslo, Norway) was dissolved in
distilled water, sterile-ﬁltered using a 0.2-lm ﬁlter and diluted
geometrically in 5-ml Nalgene tubes from 1,024 lg/ml to 0.06 lg/
ml in 2 ml of diluted BSK-H medium (diluted 1:100 in distilled
water). A 2-ml suspension of cystic forms (24 h, or 8 months) was
added to each of the RBC dilutions (and to a control tube con-
taining only diluted BSK-H) in a ﬁnal concentration between
0.03 lg/ml and 512 lg/ml – a total of 15 tubes. Susceptibility
testing for RBC was performed for motile spirochetes in a ﬁnal
dilution from 0.03 lg/ml to 256 lg/ml in non-diluted BSK-H me-
dium. The ﬁnal volume was 4 ml in each tube, and 40 ll of
107 bacteria/ml in exponential growth was added.
Incubation conditions for susceptibility testing
The cysts were tested at the ages of 1 day and 8 months. Both
categories of cysts were incubated for 2 weeks at 37 C. The motile
bacteria were incubated for 2 weeks at 30 C or 37 C in BSK-H
medium.
Examination of the ranitidine bismuth citrate-exposed microbes
The tubes with motile borrelia in BSK-H medium (RBC concen-
tration: 0.03–512 mg/ml; 0 mg/ml in the control) were examined by
DFM (200–800·) 1 week and 2 weeks after the addition of RBC to
detect the presence of any motile spirochetes. Of these non-motile
spirochetes, a 0.1-ml suspension was transferred to fresh BSK-H
medium, incubated for 2 months and subcultured every second
week.
Examination of the ranitidine bismuth citrate-exposed cysts
A total of 20 ll of the culture was transferred to a glass slide, dried,
ﬂame-ﬁxed and overlaid with acridine orange (AO; 50 mg/l) in
phosphate buﬀer (pH 6.4) for 4 min and rinsed in distilled water.
The AO-stained cysts were examined by UV microscopy (1,000–
2,000·). Vital AO-staining was performed on RBC-exposed cysts at
37 C by mixing 10 ll of AO (100 mg/l) in phosphate buﬀer
(pH 7.4) with 10 ll of culture on a glass slide protected with a
coverslip. The vitally stained cysts were examined by UV micro-
scopy (400–2,000·).
Reconversion of cystic forms to spirochetal forms
Each RBC dilution in distilled water (0.3 ml containing 106 cysts/
ml) was transferred to 4 ml of BSK-H medium (resulting in
7.5 · 104 cysts/ml) and incubated at 30 C in tightly capped tubes.
The tubes were centrifuged at 3,200 g for 30 min. The pellet was
mixed with 0.5 ml of the supernatant and examined by DFM at
200 · magniﬁcation. The formation of spirochetes from cysts was
examined at 800·. Fresh BSK-H medium, 4 ml, was added to each
tube to determine the extent of cyst conversion to normal borrelias.
This process was repeated every second week for 2 months.
Examination by transmission electron microscopy
The following cultures were examined by transmission electron
microscopy (TEM): (a) 8-month-old cysts which had been incu-
bated in distilled water with 0 lg RBC/ml (control), 1, 4, or
256 lg RBC/ml for 2 weeks at 37 C, (b) motile bacteria which
had been incubated in BSK-H medium with 0 lg RBC/ml (con-
trol), 4 lg RBC/ml, or 64 lg/ml RBC for 2 weeks at 37 C. The
cultures were centrifuged at 5,000 g for 20 min. The medium was
removed and replaced with 2% glutaraldehyde in 0.2 M cacody-
late buﬀer (pH 7.3); and the bacteria were ﬁxed for 2 h. The
bacteria were postﬁxed in 1% osmium tetroxide in 0.2 M caco-
dylate buﬀer for 2 h. The pellets were dehydrated, inﬁltrated and
embedded in conventional epoxy resin (LX-112; Ladd, Burling-
ton, Vt.) by a method described earlier [9, 10]. Ultrathin sections
were cut with a diamond knife (Jumdi; Juniper ultra Micro,
Stockholm, Sweden) on an ultramicrotome (LKB 2088 Ultrotom
V) and mounted on 200-mesh copper grids. The sections were
stained with 5% uranyl acetate in 30% ethanol for 20 min and
Reynolds lead citrate for 5 min. The sections were examined in a
Jeol 1200 EX TEM.
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Results
Susceptibility testing for cystic forms
No rupturing was observed (DFM) for any of the cysts
when incubated with RBC (0.03–512 lg/ml) for 14 days
at 37 C. When ﬁxed smears of cysts were AO-stained at
pH 6.4, the control cysts (incubated without RBC)
showed a bright orange-red color and contained distinct
core structures (Fig. 1a). When old cysts were exposed
to 4 lg RBC/ml (37 C), fewer than 10% of the cysts
revealed an orange color (Fig. 1b). The majority of the
cysts revealed partly dissolved contents and their color
was a weak green. Incubated in 8 lg RBC/ml (37 C),
the content of the cysts dissolved without distinct core
structures and appeared a weak green color. The 1-day-
old control cyst contained distinct spirochetal structures
(Fig. 2a). When 1-day-old cysts were exposed to con-
centrations of RBC higher than 0.125 lg/ml (37 C), no
distinct spirochetal structures could be seen and only
green, swollen cysts with dissolved content were
observed (Fig. 2b).
When old cysts that had been incubated for 14 days
at 37 C in RBC environment were exposed to vital AO-
staining (pH 7.4), the cores of the cysts revealed the
Fig. 1a, b Old cysts of Borrelia
burgdorferi. a Old cysts
(8 months) in distilled water
incubated at 37 C for 14 days
without ranitidine bismuth
citrate (RBC). Mainly core
structures and a few short rod
structures are observed inside
the cysts. The intensely stained
bacteria and cores indicate the
presence of signiﬁcant amounts
of RNA. Flame-ﬁxed and
stained with acridine orange. b
Old cysts incubated at 37 C for
14 days in distilled water with
4 lg RBC/ml weakly stained
green, which illustrates a low
concentration of RNA. Flame-
ﬁxed and stained with acridine
orange. Bar 6 lm
Fig. 2a, b Young cysts. a
Young cysts (1 day) incubated
in distilled water without RBC.
Distinct orange spirochetal
forms are observed inside the
cysts. b Same as a, but with a
RBC concentration of 4 lg/ml.
The swollen cysts are partly
dissolved and no distinct spi-
rochetal structures are present.
The color is weak green.
Flame-ﬁxed and acridine
orange (AO)-stained, pH 6.4.
Bar 6 lm
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following colors, depending on the concentration of
RBC: bright green for RBC<2 lg/ml (Fig. 3a), 50%
orange and 50% green cores for RBC=2 lg/ml
(Fig. 3b) and 100% yellow/orange/red core structures
for RBC>2 lg/ml (Fig. 3c). For the young cysts, the
corresponding limits for color shift by vital AO-staining
were: green for RBC<0.06 lg/ml, 90:10 orange:green
for RBC=0.125 lg/ml and yellow/orange/red for
RBC ‡ 0.25 lg/ml.
Bismuth aggregates attached to the cell envelope of
the old cysts (Fig. 4). The aggregates seemed to pene-
trate some of the cell walls when the RBC concentration
was higher than 2 lg/ml (Fig. 4a). Surprisingly, most of
the blebs were covered with bismuth aggregates. When
RBC=256 lg/ml, the 8-month-old cysts were attached
to large clusters of needle-like aggregates which pene-
trated the cyst wall (Fig. 4b). No aggregates were seen
attached to cysts or blebs when RBC=1 lg/ml (Fig. 4c).
Only a few intact blebs were visible when the concen-
tration of RBC was higher than 2 lg/ml.
Re-emergence of motile spirochetes from the cysts
When transferred to BSK-H medium, about 50% of the
cysts which had been exposed to RBC concentrations
from 0 lg/ml (control) to 2 lg/ml converted to immotile
spirochetes. Most of the converted spirochetes were
relatively short and they were attached to cysts (Fig. 5).
Spirochetes that detached from the cyst (about 5%) were
normal in appearance, except they were so thin (0.1 lm)
that they were almost impossible to photograph. No
further development of these spirochetes was observed
beyond incubation for 1 month. When the concentra-
tion of RBC was above 2 lg/ml, no spirochetes began to
protrude from cysts.
Susceptibility testing for motile spirochetes
Susceptibility testing of normal motile borrelias showed
that MBC vs RBC was >256 lg/ml when incubation
took place at 30 C for 14 days, it was >64 lg/ml when
the incubation occurred at 37 C for 7 days, and it was
>2 lg/ml when the temperature was 37 C for 14 days.
When the motile spirochetes were incubated at 37 C for
14 days, the production of cysts decreased as the con-
centration of RBC reached the MBC.
Transmission electron microscopy
No bismuth aggregates were observed by TEM on the
bacteria or the cyst when the concentration of RBC was
lower thanMBC (37 C for 14 days) (Fig. 6a). At a RBC
concentration of 4 lg/ml, only a few bismuth aggregates
were visible on the spirochetal envelope (Fig. 6b), but at
RBC concentrations >64 lg/ml, many aggregates were
attached to the spirochetes, cyst and blebs (Fig. 6c).
Discussion
Our investigation revealed high susceptibility of motile
and cystic forms of B. burgdorferi to RBC. The MBC
achieved in our study is far below the concentration
Fig. 3a–c Susceptibility testing of old cystic forms of B. burgdor-
feri, using RBC in distilled water at 37 C for 14 days. a
RBC=1 lg/ml: the cyst contains green cores (living organisms).
b RBC=2 lg/ml: the cyst contains both green and orange cores.
c RBC=256 lg/ml: The cyst contains only red core/granules
(biologically inactive organisms) and no distinct cyst/core can be
seen. Vital AO-staining, pH 7.4. Bar 5 lm
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achievable in the GI tract [19, 20, 21]. Our present study
shows that RBC also attacks the granules and blebs.
Bleb production from cysts has been demonstrated
earlier by us [6, 7]. Our observation that blebs and
granules were targets for bismuth and that few blebs
were observed when RBC ‡ MBC may be of relevance
in order to decrease the amount of cytokines and CD8+
T-lymphocytes, thereby reducing the ability of the bac-
terium and cysts to induce disease [26, 44]. Earlier, we
demonstrated the in vitro susceptibility of young cystic
forms of B. burgdorferi to metronidazole (MZ) in con-
centrations which are achievable in vivo. However, the
motile forms of this spirochete were resistant to MZ and
the blebs were not observably aﬀected [8].
The adherence of bismuth aggregates to motile and
cystic forms of B. burgdorferi and penetration into the
bacterium are very similar to what happens when
H. pylori is exposed to this polycation. The latter rec-
ognizes the glycocalyx, resulting in cell damage and
death [42]. We demonstrated that new spirochetes
emerge from cystic core structures [6]. New spirochetes
emerged from the cysts when vital AO-staining (pH 7.4)
revealed green core structures inside the cysts
(RBC<MBC), whereas yellow/orange/red AO-colora-
tion was observed when conversion to the spirochete
form was inhibited (RBC ‡ MBC). A bright green color
indicated living organisms, whereas yellow/orange/red
indicated dead organisms. The chain of shifts in
AO-coloration (bright green/yellow/orange/red) means
(from left to right) increasing uptake of AO caused by
intercalating with the phosphate–sugar backbone of
DNA, as the DNA becomes denatured in non-viable
cells [24, 31].
Fig. 4a–c Old cystic forms. a Old cystic forms incubated at 37 C
for 14 days in distilled water with 4 lg RBC/ml. Some aggregates
of bismuth (arrows) are attached to the cysts. b The same
conditions, but the RBC concentration is 256 lg/ml. Note the
increased aggregation of bismuth (arrows) to cysts and blebs,
compared with 4 lg/ml. The bismuth aggregates seem to penetrate
the envelope of the cyst. No normal blebs are seen. c Not exposed
to RBC: distinct core structures and a few short spirochetal
structures are observed inside the cysts. Some blebs are also
present. No clusters of aggregates are observed attached to the cyst.
Transmission electron microscopy (TEM), staining: uranyl acetate
and lead citrate. Bar 750 nm
b
Fig. 5 Old cysts were incubated at 37 C for 14 days in distilled
water with 1 lg RBC/ml and then transferred to BSK-H medium
(Sigma B3528). After incubation for 1 week in this medium, some
thin, immobile spirochetes (arrow) protrude from the cysts. Dark
ﬁeld microscopy. Bar 8 lm
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When RBC ‡ MBC, AO-stained ﬁxed smears at
pH 6.4 revealed cysts with a green color and no distinct
core structures could be seen, which implied no or little
intact RNA. When RBC<MBC, the cysts were red,
which implied large amounts of intact RNA [29]. The
lack of distinct orange core structures corresponded to
concentrations of RBC where spirochetes were no longer
formed from cysts.
Our study revealed an enhanced action of bismuth
when the temperature and length of incubation in-
creased. When motile spirochetes were incubated at the
relatively high temperature of 37 C, the production of
cysts was induced and was independent of the con-
centration of RBC. However, when the concentration
of RBC reached the MBC, the number of cysts de-
creased. After 14 days incubation at 37 C with 2 mg
RBC/ml, about 100 spirochetes/ml of degraded, slightly
motile forms were observed. When subcultured in fresh
medium, these bacteria did not regenerate. They died
within 14 days. Considering the sparse amount of bis-
muth crystals attached to the spirochetes at this con-
centration, the motile spirochetes are apparently more
susceptible to RBC than the cysts.
Bismuth is cytoprotective and increases the dermal
growth factor [11, 12, 13]. Therefore, bismuth is theo-
retically advantageous when B. burgdorferi causes
bleeding in the GI tract [31]. Bismuth salts may also have
beneﬁcial properties regarding action on C. diﬃcile [28],
which can be troublesome for prolonged Lyme treatment.
This is the ﬁrst susceptibility testing of motile and
cystic forms of B. burgdorferi to bismuth salts. Further,
this is the ﬁrst indication of viable cystic forms older
than 2 months [5] and the ﬁrst indication that old cysts
are more resistant to adverse environment than young
cysts. The facts that B. burgdorferi can infect the GI tract
and that both motile and even old cystic forms of
B. burgdorferi are susceptible to RBC in vitro, suggest
the agent may be of value in vivo when B. burgdorferi
infects the GI tract.
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